Professor Richard Barker to speak at Undoing Aging 2019

Mountain View, CA / Berlin, Germany

We are happy to announce Professor Richard W. Barker as a speaker for the 2019 Undoing Aging Conference.

Richard is an internationally respected leader in healthcare and life sciences. He says: "I’m focused on accelerating precision medicine technologies to advance our healthy lifespan".

Professor Barker is Founding Director of New Medicine Partners, a global firm assisting public and private sector organisations to accelerate the worldwide development and adoption of precision medicine. He is chairman of the South London Health Innovation Network and of the corresponding Genomic Medicine Centre. He also chairs Kvatchii, a digital health company bringing cardiovascular health improvement to India and other middle income economies. He is a board member of Image Analysis, a UK company using MRI to quantify the impact of therapy on disease and of Celgene, a major US-based bio-therapeutics company.

His 30-year business career in healthcare has spanned biopharmaceuticals, diagnostics and medical informatics – both in the USA and Europe. The senior roles he has held include: Director General of the Association of the British Pharmaceutical Industry, General Manager of Healthcare Solutions for IBM, Chief Executive of Chiron Diagnostics and head of McKinsey’s European healthcare practice.

His book on the future of healthcare ‘2030 - The Future of Medicine: Avoiding a Medical Meltdown’ and his second book ‘Bioscience – lost in translation?’ are published by Oxford University Press. 

​"Richard has long played a critical role in bridging several key divides between communities that have slowed progress in rejuvenation biotechnology: between researchers and clinicians, between gerontologists and other biologists, and also between scientists and policy-makers. His role as founding leader of Oxford’s Centre for the Advancement of Sustainable Medical Innovations was a shining example of this, and SENS Research Foundation were very proud to fund its first two PhD students." says Aubrey de Grey.

---